Stocktoria
Taysha Gene Therapies, Inc. TSHA
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-09-24
Taysha Gene Therapies, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| D. E. Shaw & Co., Inc. | 4,398,652 | $30.0M | 1.38% |
| BlackRock Finance, Inc. | 11,742,449 | $26.3M | 3.67% |
| MILLENNIUM MANAGEMENT LLC | 2,126,838 | $14.5M | 0.67% |
| CITADEL ADVISORS LLC | 1,713,187 | $11.7M | 0.54% |
| TWO SIGMA INVESTMENTS, LP | 234,716 | $1.6M | 0.07% |
| AQR CAPITAL MANAGEMENT LLC | 128,764 | $876,883 | 0.04% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.